Pharmacological and Biological Antiviral Therapeutics for Cardiac Coxsackievirus Infections

by Jens Kurreck, Wolfgang Poller, Henry Fechner, Anja Geisler, Sandra Pinkert
Published 2011-10-01

Exploration of Analgesia with Tramadol in the Coxsackievirus B3 Myocarditis Mouse Model

by Sandra Pinkert, Meike Kespohl, Nicolas Kelm, Ziya Kaya, Arnd Heuser, Karin Klingel, Antje Beling
Published 2021-06-01

The immunoproteasome‐specific inhibitor ONX 0914 reverses susceptibility to acute viral myocarditis

by Nadine Althof, Carl Christoph Goetzke, Meike Kespohl, Karolin Voss, Arnd Heuser, Sandra Pinkert, Ziya Kaya, Karin Klingel, Antje Beling
Published 2018-02-01

Coxsackievirus B3 Infection of Human iPSC Lines and Derived Primary Germ-Layer Cells Regarding Receptor Expression

by Janik Böhnke, Sandra Pinkert, Maria Schmidt, Hans Binder, Nicole Christin Bilz, Matthias Jung, Uta Reibetanz, Antje Beling, Dan Rujescu, Claudia Claus
Published 2021-01-01

A novel artificial microRNA expressing AAV vector for phospholamban silencing in cardiomyocytes improves Ca2+ uptake into the sarcoplasmic reticulum.

by Tobias Gröβl, Elke Hammer, Sandra Bien-Möller, Anja Geisler, Sandra Pinkert, Carsten Röger, Wolfgang Poller, Jens Kurreck, Uwe Völker, Roland Vetter, Henry Fechner
Published 2014-01-01

Anti-adenoviral Artificial MicroRNAs Expressed from AAV9 Vectors Inhibit Human Adenovirus Infection in Immunosuppressed Syrian Hamsters

by Katrin Schaar, Anja Geisler, Milena Kraus, Sandra Pinkert, Markian Pryshliak, Jacqueline F. Spencer, Ann E. Tollefson, Baoling Ying, Jens Kurreck, William S. Wold, Robert Klopfleisch, Karoly Toth, Henry Fechner
Published 2017-09-01